The Association of ApoE Genotype and Cognitive Impairment in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis

The Association of ApoE Genotype and Cognitive Impairment in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سپیده سیدی صاحباری , امیررضا ناصری , مهناز طالبی

عنوان کنگره / همایش: Eighth MENACTRIMS Congress , United Arab Emirates , Abu Dhabi , 2023

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله سپیده سیدی صاحباری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه کمیته تحقیقات دانشجویی
کد مقاله 83662
عنوان فارسی مقاله The Association of ApoE Genotype and Cognitive Impairment in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
عنوان لاتین مقاله The Association of ApoE Genotype and Cognitive Impairment in Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
نوع ارائه پوستر
عنوان کنگره / همایش Eighth MENACTRIMS Congress
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش United Arab Emirates
شهر محل برگزاری کنگره/ همایش Abu Dhabi
سال انتشار/ ارائه شمسی 1402
سال انتشار/ارائه میلادی 2023
تاریخ شمسی شروع و خاتمه کنگره/همایش 1402/09/17 الی 1402/09/18
آدرس لینک مقاله/ همایش در شبکه اینترنت https://www.sciencedirect.com/science/article/abs/pii/S2211034823007186
آدرس علمی (Affiliation) نویسنده متقاضی Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سپیده سیدی صاحباریاول
امیررضا ناصریدوم
مهناز طالبیسوم

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیApoE Genotype، Cognitive Impairment، Multiple Sclerosis، Systematic Review، Meta-Analysis
خلاصه مقالهBackground/Objective(s) Multiple Sclerosis (MS) is a neuroinflammatory disease with an autoimmune etiology. Cognitive impairment is one of the most prevalent symptoms of MS which affect nearly 40% to 70% of patients. Apolipoprotein E (ApoE) genotype is known to have a significant association with cognitive disorders. The E4 allele of ApoE has shown a significant relation with the increased risk of Alzheimer's Disease (AD) and has been detected in 40–80% of patients with AD. Material(s) and Method(s) Following the PRISMA statement, a systematic search was conducted though Medline via PubMed, Scopus, and ISI web of science and studies which assessed the association between ApoE and cognitive impairment based on the Brief Visuospatial Memory Test - Revised (BVMT-R), the California Verbal Learning Test- II (CVLT-II), and the Delis-Kaplan Executive Function System (DKFES) tests, in MS patients included in this study. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools and the meta-analysis was conducted with Comprehensive Meta-Analysis (CMA.2) software. Result(s) Out of 224 identified records, 16 records were screened in the title/abstract stage and finally, 3 studies were included. Considering a low risk of bias in these 3 studies, evaluating the cognitive impairment in MS patients showed that, based on BVMT-R (OR: 1.59, 95% CI: 0.88 - 2.86, p=0.12), CVLT-II (OR: 1.59. 95% CI: 0.84 - 3,p=0.15) and DKEFS (OR: 1.54, 95% CI: 0.66 - 3.59, p=0.32) tests, ApoE4 allele doesn't have a significant role in cognitive impairment of MS patients. Conclusion(s) ApoE4 doesn't have a specific association with cognitive impairment in MS patients.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
File_d7ee9a7174334062889cd88dcb26e1c9-63568118.pdf1402/12/07139289دانلود
SEPIDEH SEYEDISAHEBARI MRS.pdf1402/12/0744752دانلود
SEYEDISAHEBARI SEPIDEH MRS.pdf1402/12/07101398دانلود
IMG_8087.jpg1402/12/07168302دانلود
IMG_8089.jpg1402/12/07166636دانلود
IMG_8088.jpg1402/12/07353290دانلود
P307.pdf1402/10/203597499دانلود
ApoE4.pdf1402/11/091551980دانلود